Pluristem Therapeutics Inc (PSTI)

[Scott999]

Too thinly may be the operative word there Jasper. In CLI, the patients are followed for 3 years, so we have a while for that. Hip study, they are followed for a year. ARS...needs to start then I'd imagine 6 months to a year. Japan fast track is just a joke. So without a partnership with some cash, I don't see us making it to any finish line without serious dilution.

Hence the concern going to a ton of shows. Maybe they are anticipating something big and then want to promote it. Month and a half to year end. Hoping we get some clarity on something from them, not just the usual rehashing of stuff we already know. I/C results will be extremely important and better be clearly positive. Otherwise that casts serious doubts on CLI as well.